DK1115417T3 - Anvendelse af daptomycin - Google Patents

Anvendelse af daptomycin

Info

Publication number
DK1115417T3
DK1115417T3 DK99949913T DK99949913T DK1115417T3 DK 1115417 T3 DK1115417 T3 DK 1115417T3 DK 99949913 T DK99949913 T DK 99949913T DK 99949913 T DK99949913 T DK 99949913T DK 1115417 T3 DK1115417 T3 DK 1115417T3
Authority
DK
Denmark
Prior art keywords
daptomycin
administering
muscle toxicity
skeletal muscle
effective amount
Prior art date
Application number
DK99949913T
Other languages
English (en)
Inventor
Frederick B Oleson Jr
Francis P Tally
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26798675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1115417(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Application granted granted Critical
Publication of DK1115417T3 publication Critical patent/DK1115417T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK99949913T 1998-09-25 1999-09-24 Anvendelse af daptomycin DK1115417T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10182898P 1998-09-25 1998-09-25
US12575099P 1999-03-24 1999-03-24

Publications (1)

Publication Number Publication Date
DK1115417T3 true DK1115417T3 (da) 2006-07-31

Family

ID=26798675

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06006697.4T DK1674107T3 (da) 1998-09-25 1999-09-24 Anvendelse af daptomycin
DK99949913T DK1115417T3 (da) 1998-09-25 1999-09-24 Anvendelse af daptomycin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06006697.4T DK1674107T3 (da) 1998-09-25 1999-09-24 Anvendelse af daptomycin

Country Status (26)

Country Link
US (2) US6468967B1 (da)
EP (2) EP1674107B8 (da)
JP (4) JP4184607B2 (da)
KR (2) KR20010075327A (da)
CN (2) CN1150029C (da)
AT (1) ATE322280T1 (da)
AU (1) AU764348B2 (da)
BR (1) BR9914051A (da)
CA (1) CA2344318C (da)
CY (3) CY1105556T1 (da)
DE (3) DE122006000049I1 (da)
DK (2) DK1674107T3 (da)
ES (2) ES2603086T3 (da)
HK (1) HK1040363B (da)
HU (1) HU230656B1 (da)
IS (2) IS5890A (da)
LU (1) LU91254I2 (da)
NL (1) NL300232I2 (da)
NO (1) NO20011454L (da)
NZ (1) NZ510690A (da)
PL (2) PL206091B1 (da)
PT (2) PT1115417E (da)
RU (1) RU2363489C9 (da)
SI (2) SI1115417T1 (da)
TR (1) TR200100841T2 (da)
WO (1) WO2000018419A2 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1674107T3 (da) 1998-09-25 2016-12-19 Cubist Pharmaceuticals Llc Anvendelse af daptomycin
CN1425025A (zh) 1999-12-15 2003-06-18 卡比斯特制药公司 作为抗菌剂的新颖的脂肽
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
WO2002059145A1 (en) * 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
NZ571597A (en) 2000-12-18 2010-05-28 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified daptomycin lipopeptides
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050277581A1 (en) * 2002-11-18 2005-12-15 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050220862A1 (en) 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
US20080051326A1 (en) * 2004-11-12 2008-02-28 Alexander Dylan C Antiinfective Lipopeptides
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070238630A1 (en) * 2006-03-29 2007-10-11 Phillips Douglas H Subcutaneous skin cleanser
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
TW200940552A (en) * 2008-03-04 2009-10-01 Elan Pharm Inc Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
EP2320933B1 (en) 2008-07-17 2017-12-27 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
DE102008046610A1 (de) * 2008-09-09 2010-03-11 Biomet Deutschland Gmbh Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
US8809263B2 (en) * 2008-10-24 2014-08-19 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Anti-infective hydroxy-phenyl-benzoates and methods of use
EP2379580B1 (en) 2008-12-22 2013-10-23 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of gram positive infections
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2011008193A1 (en) * 2009-07-13 2011-01-20 Cempra Pharmaceuticals Inc. Fusidic acid dosing regimens for treatment of bacterial infections
US8450300B2 (en) * 2009-07-13 2013-05-28 Cempra Pharmaceuticals Inc. Fusidic acid dosing regimens for treatment of bacterial infections
MX353288B (es) 2009-09-04 2018-01-08 Raptor Pharmaceuticals Inc Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica.
JP6041673B2 (ja) 2009-11-23 2016-12-14 キュービスト ファーマシューティカルズ リミテッド ライアビリティ カンパニー リポペプチド組成物および関連する方法
US8247394B2 (en) 2010-06-02 2012-08-21 Cempra Pharmaceuticals Inc. Methods of treating urethritis and related infections using fusidic acid
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8461188B2 (en) 2011-10-20 2013-06-11 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc １，３，４－□二唑及１，３，４－噻二唑β－內醯胺酶抑制劑
MX366122B (es) * 2012-09-11 2019-06-27 Hospira Australia Pty Ltd Formulaciones de daptomicina y usos de la misma.
CN103006562B (zh) * 2013-01-21 2014-09-17 西南大学 达托霉素醇质体制剂
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
CN109310735A (zh) * 2016-05-13 2019-02-05 我希望增效剂公司 新阳离子肽spr741对抗生素活性的增效作用
CN114788814B (zh) * 2021-01-26 2023-10-13 浙江创新生物有限公司 一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4800157A (en) 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
CA2011365A1 (en) * 1989-03-06 1990-09-06 Eugene L. Inman Diluent formulation for daptomycin
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
DK1674107T3 (da) 1998-09-25 2016-12-19 Cubist Pharmaceuticals Llc Anvendelse af daptomycin
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Also Published As

Publication number Publication date
PL348328A1 (en) 2002-05-20
CA2344318A1 (en) 2000-04-06
CN1348382A (zh) 2002-05-08
US6852689B2 (en) 2005-02-08
AU764348B2 (en) 2003-08-14
JP4184607B2 (ja) 2008-11-19
PT1115417E (pt) 2006-07-31
CY2006003I2 (el) 2009-11-04
JP2002525335A (ja) 2002-08-13
JP2003321389A (ja) 2003-11-11
RU2004106569A (ru) 2005-08-10
CY1105556T1 (el) 2010-07-28
DK1674107T3 (da) 2016-12-19
CN1150029C (zh) 2004-05-19
EP1674107A8 (en) 2006-10-04
IS8807A (is) 2009-03-10
ES2259845T3 (es) 2006-10-16
EP1674107A3 (en) 2012-06-20
RU2363489C9 (ru) 2010-03-20
HK1040363B (zh) 2007-01-26
SI1115417T1 (sl) 2006-08-31
CY1118334T1 (el) 2017-06-28
EP1115417A2 (en) 2001-07-18
EP1674107A2 (en) 2006-06-28
PT1674107T (pt) 2016-12-07
EP1674107B1 (en) 2016-08-24
WO2000018419A2 (en) 2000-04-06
PL203689B1 (pl) 2009-11-30
NL300232I2 (nl) 2007-01-02
NO20011454L (no) 2001-05-25
CA2344318C (en) 2006-07-04
EP1115417B1 (en) 2006-04-05
HUP0103874A2 (hu) 2002-02-28
ATE322280T1 (de) 2006-04-15
BR9914051A (pt) 2001-06-19
SI1674107T1 (sl) 2017-01-31
JP2004339238A (ja) 2004-12-02
NL300232I1 (nl) 2006-09-01
HUP0103874A3 (en) 2002-09-30
NZ510690A (en) 2002-10-25
DE122006000049I2 (de) 2007-11-08
IS5890A (is) 2001-03-14
NO20011454D0 (no) 2001-03-22
JP2006335773A (ja) 2006-12-14
AU6268799A (en) 2000-04-17
US6468967B1 (en) 2002-10-22
DE69930758D1 (de) 2006-05-18
KR20010075327A (ko) 2001-08-09
EP1674107B8 (en) 2017-01-25
US20020142948A1 (en) 2002-10-03
TR200100841T2 (tr) 2002-01-21
DE69930758T2 (de) 2007-04-26
HK1040363A1 (en) 2002-06-07
PL206091B1 (pl) 2010-06-30
CY2006003I1 (el) 2009-11-04
ES2603086T3 (es) 2017-02-23
HU230656B1 (hu) 2017-06-28
DE122006000049I1 (de) 2007-01-04
WO2000018419A3 (en) 2000-07-06
LU91254I2 (fr) 2006-08-28
KR20100051735A (ko) 2010-05-17
RU2363489C2 (ru) 2009-08-10
CN1530136A (zh) 2004-09-22

Similar Documents

Publication Publication Date Title
DK1115417T3 (da) Anvendelse af daptomycin
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DK1201246T3 (da) Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
SE9803623D0 (sv) New therapeutic application